[Endometrial carcinoma during estrogen replacement therapy in spite of addition of progestagens].
Ubachs
J M
JM
De Wever Ziekenhuis, afd. Verloskunde en Gynaecologie, Heerlen.
Heineman
M J
MJ
D000230:Adenocarcinoma / Q000139:chemically induced* / Q000601:surgery; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D005260:Female; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage*; D008875:Middle Aged; D014594:Uterine Neoplasms / Q000139:chemically induced* / Q000601:surgery
D017258:Medroxyprogesterone Acetate
Endometriumcarcinoom tijdens substitutietherapie met oestrogeen ondanks toevoeging van progestageen.